Cases & Deals

Special committee of pharmaceutical company investigates shareholder derivative demand

Clients Special committee of pharmaceutical company

Jones Day represented a special committee of the board of directors of a pharmaceutical company in conducting an internal investigation in response to a shareholder derivative demand letter regarding certain alleged breaches of fiduciary duty relating to a financial restatement. The special committee rejected the demand. The shareholders did not challenge this decision.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.